-
1Academic Journal
Συγγραφείς: N. K. Vereina, T. V. Movchan, V. S. Chulkov, Н. К. Вереина, Т. В. Мовчан, В. С. Чулков
Πηγή: Aterotromboz = Atherothrombosis; № 1 (2020); 18-32 ; Атеротромбоз; № 1 (2020); 18-32 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2017-3
Θεματικοί όροι: молодой возраст, arterial thrombosis, venous thromboembolism, women, young age, артериальные тромбозы, венозный тромбоэмболизм, женщины
Περιγραφή αρχείου: application/pdf
Relation: https://www.aterotromboz.ru/jour/article/view/211/237; Бойцов С.А., Чучалин А.Г. (ред.). Диспансерное наблюдение больных хроническими неинфекционными заболеваниями и пациентов с высоким риском их развития. М.; 2014. 112 с. Режим доступа: https://minzdrav.midural.ru/upbads/document/1896/dispansernoe-nabIyude-nie-bolnyh-hniz-sa-chuchalin.pdf.; Воевода М.И., Ковалькова Н.А., Рагино Ю.А., Травникова Н.Ю., Денисова Д.В. Распространенность метаболического синдрома у жителей Новосибирска в возрасте от 25 до 45 лет. Терапевтический архив. 2016;88(10):51-56. doi:10.17116/terarkh2016881051; Eichinger S., Evers J.L.H., GLasier A., La Vecchia C., MartineLLi I., Skouby S. et aL. Venous thromboembolism in women: a specific reproductive health risk. Human Reproduction Update. 2013;19(5):471-482. doi:10.1093/humupd/dmt028.; Heinemann L.A., Dinger J.C. Range of published estimates of venous thromboembolism incidence in young women. Contraception. 2007;75(5):328-336. doi:10.1016/j.contraception.2006.12.018.; PutaaLa J. Ischemic stroke in the young: Current perspectives on incidence, risk factors, and cardiovascuLar prognosis. European Stroke Journal. 2016;1(1):28-40. doi:10.1177/2396987316629860.; PutaaLa J., Antti J., Metso A.J., Metso T.M., Konkola N., Kraemer Y et aL. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke. The Helsinki Young Stroke Registry. Stroke. 2009;40(4):1195-1203. doi:10.1161/STROKEAHA.108.529883.; WeiLL A., DaLichampt M., Raguideau F., Ricordeau Ph., BLotire P.-O., Rudant J. et aL. Low dose oestrogen combined oraL contraception and risk of puLmonary emboLism, stroke, and myocardiaL infarction in five miLLion French women: cohort study. BMJ. 2016;353. doi:10.1136/bmj.i2002.; Izadnegahdar M., Singer J., Lee M.K., Gao M., Thompson C.R., Kopec J., Humphries K.H. Do younger women fare worse? Sex differences in acute myocardiaL infarction hospitaLization and earLy mortaLity rates over ten years. J Women’s HeaLth. 2014;23(1):10-17. doi:10.1089/jwh.2013.4507.; Chandrasekhar J., GiLL A., Mehran R. Acute myocardiaL infarction in young women: current perspectives. Int J Womens Health. 2018;10:267-284. doi:10.2147/IJWH.S107371.; Lacruz B., Tiberio G., Latorre A., ViLLaLba J.C., BikdeLi B., Hirmerova J. et aL. RIETE Investigators Venous thromboemboLism in young aduLts: Findings from the RIETE registry. Eur J Intern Med. 2019;63:27-33. doi:10.1016/j.ejim.2019.02.007.; WendeLboe A.M., Raskob G.E. GLobaL burden of thrombosis: epidemioLogic aspects. Circulation Research. 2016;118(9):1340-1347. doi:10.1161/CIRCRESAHA.115.306841.; Prandoni P., Lensing A.W., Cogo A., Cuppini S., ViLLaLta S., Carta M. et aL. TheLong-term cLinicaL course of acute deep venous thrombosis. Ann Intern Med. 1996;125(1):1-7. doi:10.7326/0003-4819-125-1-199607010-00001.; Prandoni P. Venous and arteriaL thrombosis: Two aspects of the same disease? Clinical Epidemiology. 2009;2009(1):1-6. doi:10.2147/cLep.s4780.; PrevitaLi E., BucciareLLi P., Passamonti S.M., MartineLLi I. Risk factors for venous and arteriaL thrombosis. Blood Transfus. 2011;9(2):120-138. doi:10.2450/2010.0066-10.; Prandoni P. Venous and arteriaL thrombosis: is there aLink? In: IsLam M. (ed.) Thrombosis and Embolism: From Research to Clinical Practice. 2016, pp. 273-283. doi:10.1007/5584_2016_121.; Prandoni P. Is there aLink between venous and arteriaL thrombosis? A reappraisaL. Int Emerg Med. 2020;15(1):33-36. doi:10.1007/s11739-019-02238-6.; Lind C., FLinterman L.E., Enga K.F., Severinsen M.T., Kristensen S.R., Braekkan S.K., Mathiesen E.B. Impact of incident venous thromboemboLism on risk of arteriaL thrombotic diseases. Circulation. 2014;129(8):855-863. doi:10.1161/CIRCULATIONAHA.113.004168.; Maino A., ALgra A., Peyvandi F., RosedaaL F.R., Siegerink B. HypercoaguLabiLity and the risk of recurrence in young women with myocardiaL infarction or ischaemic stroke: a cohort study. BMC Cardiovasc Disord. 2019;19:55. doi:10.1186/s12872-019-1040-4.; Андрияшкин А.В., Андрияшкин В.В., Арутюнов Г.П., Баринов В.Е., Бицадзе В.О., Бодыхов М.К. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО). Флебология. 2015;9(4-2):1-52. Режим доступа: https://docpLayer.ru/65249323-Rossiyskie-kLin-icheskie-rekomendacii-po-diagnostike-Lecheniyu-i-profiLaktike-venoznyh-tromboemboLicheskih-osLozh-neniy-vteo.htmL.; Myakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R. et aL. International consensus statement on an update of the cLassification criteria for definite antiphosphoLipid syndrome. J Thromb Haemost. 2006;4(2):295-306. doi:10.1111/j.1538-7836.2006.01753.x.; RosendaaL F.R. Venous thromboemboLism: the roLe of genes, environment, and behavior. Hematology. Am Soc Hematol. Education Program. 2005;1:1-12. doi:10.1182/asheducation-2005.1.1.; Kearon C., Ageno W., Cannegieter S.C., Cosmi B., Geersing G.J., KyrLe P.A. Categorization of patients as having provoked or unprovoked venous thromboemboLism: guidance from the SSC of ISTH. J Thrombosis and Haemostasis. 2016;14(7):1480-1483. doi:10.1111/jth.13336.; MiLLett E.R.C., Peters S.A.E., Woodward M. Sex differences in risk factors for myocardiaL infarction: cohort study of UK Biobank participants. BMJ. 2018;363:k4247. doi:10.1136/bmj.k4247.; World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: WHO; 2015. 267 p Available at: https://www.who.int/reproductivehe-aIth/pubIications/famiIy_pIanning/MEC-5/en/; Dragoman M.V., Tepper N.K., Fu R., Curtis K.M., Chou R., Gaffield M.E. A systematic review and metaanalysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141(3):287-294. doi:10.1002/ijgo.12455.; Lidegaard O., Lokkegaard E., Svendsen A.L., Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890. doi:10.1136/bmj.b2890.; Roach R.E., Helmerhorst F.M., Lijfering W.M., Stijnen T., Algra A., Dekkers O.M. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst. Rev. 2015;2015(8):CD011054. doi:10.1002/14651858.CD011054.pub2.; Lidegaard O., Lokkegaard E., Jensen A., Skovlund C.W., Keiding N. Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception. N Engl J Med. 2012;366:2257-2266. doi:10.1056/NEJMoa1111840.; Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.-A., Harjola V.-P. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603. doi:10.1093/eurheartj/ehz405.; Bhat V.M., Cole J.W., Sorkin J.D., Wozniak M.A., Malarcher A.M., Giles W.H. et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke. 2008;39(9):2439-2443. doi:10.1161/STROKEAHA.107.510073.; Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. Jama. 2007;297(6):611-619. doi:10.1001/jama.297.6.611.; Deguchi H., Pecheniuk N.M., Elias D.J., Averell P.M., Griffin J.H. High-densitylipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation. 2005;112:893 -899. doi:10.1161/CIRCULATIONAHA.104.521344.; Ray J. Dyslipidemia, statins and venous thrombo-embolism: a potential risk factor and a potential treatment. Curr Opin Pulm Med. 2003;9(5):378-384. doi:10.1097/00063198-200309000-00007.; Ruckerl R., Ibald-Mulli A., Koenig W., Woelke G., Cyrys J., Heinrich J. et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173(4):432-441. doi:10.1164/rccm.200507-1123OC.; Baccarelli A., Martinelli I., Zanobetti A., Grillo P., Hou L.F., Bertazzi P.A. et al. Exposure to particu-late air pollution and risk of deep vein thrombosis. Arch Int Med. 2008;168(9):920-927. doi:10.1001/archinte.168.9.920.; https://www.aterotromboz.ru/jour/article/view/211
-
2Academic Journal
Συγγραφείς: A. V. Vorob'ev, U. V. Zimovina, I. Z. Kvikviniya, А. В. Воробьев, У. В. Зимовина, И. З. Квиквиния
Πηγή: Obstetrics, Gynecology and Reproduction; Vol 8, No 2 (2014); 27-33 ; Акушерство, Гинекология и Репродукция; Vol 8, No 2 (2014); 27-33 ; 2500-3194 ; 2313-7347
Θεματικοί όροι: ПРОФИЛАКТИКА ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ, thrombophilia, arterial thrombosis, prophylaxis of thrombotic complication, ТРОМБОФИЛИЯ, АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ
Περιγραφή αρχείου: application/pdf
Relation: https://www.gynecology.su/jour/article/view/74/75; Григорян О.Р., Андреева, Е.Н., Дедов И.И. Менопаузальный синдром у женщин с нарушениями углеводного обмена. Научно-практическое руководство (второе издание). М. 2011.; Макацария А.Д., Бицадзе О.В. Тромбофилические состояния в акушерской практике. М. 2001; 704 с.; Макацария А.Д., Мищенко А.Л., Бицадзе В.О. Синдром диссеминированного внутрисосудистого свертывания крови в акушерской практике. М. 2002; 523 с.; Макацария А.Д., Бицадзе О.В. Тромбофилии и противотромботическая терапия в акушерской практике. М. 2003; 904 с.; Овсянникова Т.В., Шешукова Н.А. Возможности заместительной гормональной терапии в зависимости от периода климактерия. Гинекология. 2007; 9 (2).; Beral V., Banks E., Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therap. Lancet. 2002; 360 (9337): 942-944.; Braunstein J.B., Kershner D.W., Bray P., Gerstenblith G. et al. Interaction of Hemostatic Genetics With Hormone Therapy: New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest. 2002; 121 (3): 906-920.; Braunstein J.В., Kershner D.W, Gerstenblith G. et al. Interaction of Hemostatic Genetics With Hormone Therapy: New Insights To Explain Arterial Thrombosis in Postmenopausal Women. CHEST. 2002; 121: 906-20.; Brenner B.R., Kosch A., Manco-Johnson M., Laposata M. Diagnostic Studies for Thrombophilia in Women on Hormonal Therapy and During Pregnancy, and in Children. Arch. Pathol. Lab. Med. 2002; 126: 1296-303.; Cano A., Van Baal W M. The mechanisms of thrombotic risk induced by hormone replacement therapy. Maturitas. 2001; 40: 17-38.; Cushman M., Kuller L.H., Prentice R. et al. Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. J.A.M.A. 2004; 292 (13): 1573-80.; Cushman M. Effects of Hormone Replacement Therapy and Estrogen Receptor Modulators on Markers of Inflammation and Coagulation. Amer. J. Cardiol. 2002; 90: 7F-10F.; Girolami A., Simioni P., Tormene D. APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems. Haematologica. 2000; 85 (3): 225-6.; Grodstein F., Manson J.E., Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. A prospective, observational study. Ann. Intern. Med. 2001; 135 (1): 1-8.; Goudev A., Georgiev D. В., Koycheva N. et al. Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas. 2002; 43; 49-53.; Heckbert S.N.L., Lemaitre R.N., Reiner A. et al. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. J.A.M.A. 2004; 292 (13): 1581-7.; Herrington D.M., Klein K.P. Effects of Estrogen on Thrombosis and Inflammation. Rev. Cardiovasc. Med. 2002; 3 (1): 49-56.; Herkert O., Kuhl H., Sandow J., Busse R., Schini-Kerth V.B. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation. 2001 Dec 4; 104 (23): 2826-31.; Hodis H.N., Mack W.J., Lobo R.A. et al. Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2001; 135 (11): 939-53.; Hoibraaten E., Qvigstad E., Arnesen H. et al. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, doubleblind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb. Haemost. 2000; 84 (6): 961-967.; Khan M.A., Heagerty A.M., Kitchener H., McNamee R., Cherry' N.M., Hannaford P. Oestrogen and women's heart disease: ESPRIT-UK. QJM. 2000; 93 (10): 699-700.; Koh К.К. Effects of estrogen on the vascular wall: vasomotor function and Inflammation. Cardiovasc. Res. 2002; 55: 714-26.; Lowe G., Woodward M., Vessey M. et al. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Thromb. Haemost. 2000; 83 (4): 530-5.; Lu H., Higashikata T, Inazu A. et al. Association of Estrogen Receptor-a Gene Polymorphisms With Coronary Artery Disease in Patients With Familial Hypercholesterolemia. Arterioscler. Thromb. Vase. Biol. 2002; 22: 821-7.; Luyer P., Khosla S., Owen W.G., V. Miller. M. Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women. J. Clin. Endocrinol. Metab. 2001; 86: 3629-34.; Manson J.E., Hsia J., Johnson K.C. et al. Women’s Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 2003; 349 (6): 523-34.; Nelson H.D. Assessing Benefits and Harms of Hormone Replacement Therapy: Clinical Applications. JAMA. 2002; 288 (7): 882-884.; Psaty B.M., Smith N.L., Lemaitre R.N. et al. Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women. JAMA. 2001; 285 (7): 906-913.; Raghvendra K., Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Amer. J. Physiol. Renal. Physiol. 2001; 280: F365-88.; Pare G., Krust A., Karas R. H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M. E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ. Res. 2002; 90 (10): 1087-92.; Peeyananjarassri K., Baber R. Effects of lowdose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric. 2005; 8 (1): 13-23.; Pradhan A.D., Manson J.A., Rossouw J.E. et al. Inflammatory biomarkers, hormone replacement therapy and incidence of coronary heart disease. J.A.M.A. 2002; 288: 980-7.; Rosendaal F.R., Vlieg A.V.H., Tanis B.C, Helmelhorst F.M. Estrogens, Progesterons and thorombosis. J. Thromb. Haemost. 2003; 1: 1371-80.; Rosendaal F.R., Vessey M., Rumley A. et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br. J. Haematol. 2002; 166 (4): 851-854.; Scarabin P.Y., Oger E., Plu-Bureau G. Estrogen and ThromboEmbolism Risk Study Group. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003; 9382 (362): 428-432.; Schuit S.C.E., Oei H.H., Witteman J.C.M. et al. Estrogen Receptor Gene Polymorphisms and Risk of Myocardial Infarction. JAMA. 2004; 291 (24): 2969-2977.; Seelig M.S., Altura B.M., Altura В.Т. Benefits and Risks of Sex Hormone Replacement in Postmenopausal Women. J. Amer. Coll. Nutr. 2004; 23 (5): 482-96.; Stork S., van der Schouw Y.T., Grobbee D.E. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab. 2004; 15 (2): 66-72.; Tempfer C.B., Riener E.K., Hefler L.A., Huber J.C., Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril. 2004; 82 (1): 132-137.; The Women’s Health Initiative Hormone Trials: Implications for Menopausal and Posmenopausal Women. 5th International Symposium on Women’s Health and menopause. Florence, 2004.; https://www.gynecology.su/jour/article/view/74
Διαθεσιμότητα: https://www.gynecology.su/jour/article/view/74
-
3Academic Journal
Συγγραφείς: Воробьев, А., Зимовина, У., Квиквиния, И.
Θεματικοί όροι: ЗАМЕСТИТЕЛЬНАЯ ГОРМОНАЛЬНАЯ ТЕРАПИЯ, ТРОМБОФИЛИЯ, АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ПРОФИЛАКТИКА ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ
Περιγραφή αρχείου: text/html
-
4Academic Journal
Συγγραφείς: Бокарев, И., Попова, Л.
Θεματικοί όροι: АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ВЕНОЗНЫЕ ТРОМБОЗЫ, ПРОФИЛАКТИКА ТРОМБОЗОВ
Περιγραφή αρχείου: text/html
-
5Academic Journal
Θεματικοί όροι: АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ИНСУЛЬТ, БЕРЕМЕННОСТЬ, ТРОМБОФИЛИЯ
Περιγραφή αρχείου: text/html
-
6Academic Journal
Συγγραφείς: Regina Georgiyeva Goloeva, Z S Alekberova, E S Mach, V E Tankovsky, L A Kalashnikova, Р. Г. Голоева, Земфира Садуллаевна Алекберова
Πηγή: Rheumatology Science and Practice; Vol 48, No 2 (2010); 51-58 ; Научно-практическая ревматология; Vol 48, No 2 (2010); 51-58 ; 1995-4492 ; 1995-4484 ; 10.14412/1995-4484-2010-2
Θεματικοί όροι: аневризмы артерий, venous and arterial thromboses, arterial aneurysms, венозные и артериальные тромбозы
Περιγραφή αρχείου: application/pdf
Relation: https://rsp.mediar-press.net/rsp/article/view/1256/927; Aлекберова З.С. Болезнь Бехчета. М., 2007;97с. Behcet's H. Über rezidivierende aphthö se, durch ein Virus verursachte Geschwii re am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937;105:1152-5. Jensen T. Ulcerous hemorrhagic colitis associated with Behcet's syndrome. Ugeskrift För Laeger 1941b;106:176-80. Berlin C. Behcet's syndrome with involvement of central nervous system. Report of a case, with necropsy, of lesions of the mouth, genitalia and eyes; review of the literature. Arch Dermatol Syph (Chicago) 1944;49:227-33. Sugioka I., Ohe H., Tanaka T. Two cases of hip joint deformation associated with Behcet's syndrome. Orthop Surg Traumatol 1966;15:131. Zouboulis C, Keitel W. A Historical Review of early descriptions of Adamantiades-Behcet's disease. J Invest Dermatol 2002;119:201-5. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80. Zouboulis C, Vaiopoulos G, Macromichelakis N. et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades -Behcet's disease in Greece. Clin Exp Rheum 2003;21(Suppl. 30):19-26. Yazici H., Esen F. Mortality in Behcet's syndrome. Clin Exp Rheumatol 2008;26:138-40. Kaklamani V., Vaiopoulos G., Kaklamanis P. Behcet's disease. Semin Arthritis Rheum 1998;27:197-217. Koc Y., Gullu I., Akpek G. et al. Vascular involvement in Behcet's disease. J Rheumatol 1992;19:402-10. Gurler A., Boyvat A, Tursen U. Clinical manifestations of Behcet's disease: an analysis of 2147 patients. Yonsei Med J 1997;38:423-7. Jesus H. de, Rosa M., Queiroz M.V. Vascular involvement in Behcet's disease. Ananalysis of twelve cases. Clin Rheum 1997;16:220-1. Zouboulis Ch., Kötter I., Djawari D. et al. Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe. Yonsei Med J 1997;38:411-22. Benamour S., Zeroual B., Bennis R. et al. Mala-die de Behcet-316 cases. La Presse Medicale 1990;19:1485-9. Shimizu T., Ehrlich G., Inaba G. et al. Behcet's disease (Behcet's syndrome). Sem Arthritis Rheum 1979;8(4):223-60. Hamza M. Angio Behcet. Paris: Elsevier Science Publishers B.V., 1993;7. Yazici H., Basaran G., Hamuryan V. et al. The ten-year mortality in Behcet's syndrome. Br J Rheumatol 1996;35:139-41. Ames P., Steuer A., Pap A. et al. Thrombosis in Behcet's disease: a retrospective survey from a single UK center. Rheumatology 2001;40:652-5. Zouboulis Ch. Epidemiology of Adamantiades-Behcet's disease. BD News 2001;2:3-4. Kaklamani V., Kaklamanis P. Treatment of Behcet's disease: an update. Sem Arthr Rheum 2001;30:299-312. Tugal-Tutkun I., ?nal S., Altan Yayciolglu R. Uveitis in Behcet's disease: an analysis of 880 patients. Am J Ophthalmol 2004;138:373-80. Al-Otaibi L., Porter S., Poate T. Behcet's disease: A review. J Dent Res 2005;84:209. Cho Y., Jung J., Lee K. et al. Clinical features of patients with Behcet's disease and epididymitis. J Urol 2003;170:1231. Kuzu M., Ozaslan C., Köksoy C. et al. Vascular involvement in Behcet's disease: 8-year audit. World J Surg 1994;18(6):948-54. Behcet's disease Research Committee of Japan. Behcet's disease: guide to diagnosis of Behcet's disease. Jpn J Opht 1974;18:291-4. Houman H., Lamloum M., Ben Ghorbel I. et al. Vena cava thrombosis in Behcet's disease. Analysis of a series of 10 cases. Ann Med Intern 1999;150:587-90. Pasic M., Senning A., von Segesser L. et al. Transcaval liver resection with hepatoatrial anastomosis for treatment of patients with Budd-Chiari syndrome. J Thorac Cardiovasc Surg 1993;106:275-82. Wang Z., Zhu Y., Wang S. et al. Recognition and management of Budd-Chiari syndrome: report of one hundred cases. J Vasc Surg 1989;10:149-56. Orloff M.J., Orloff M.S., Daily P. Longterm results of treatment of Budd-Chiari syndrome with portal decompression. Arch Surg 1992;127:1182-8. Uskudar O., Akdogan M., Sasmaz N. et al. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol 2008;14(8):2858-62. Maruyama R., Kumaki T., Miyashita M. et al. Case of Behcet's syndrome accompanied by Budd-Chiari syndrome. Naika 1967;19(5):959-64. Temizoz O., Genchellac H., Yekeler E. CT-angiographic demonstration of hepatic collateral pathways due to superior vena cava obstruction in Behcet's disease. Diagn Interv Radiol 2009 Oct., doi:10.4261/1305-3825.DIR.2174-08.2. Siva A., Saip S. The spectrum of nervous system involvement in Behcet's syndrome and its differential diagnosis. J Neurol 2009;256:513-29. Wechsler B., Vidailhet M., Piette J. et al. Cerebral venous thrombosis in Behcet's disease: clinical study and long-term follow-up of 25 cases. Neurology 1992;42:614-8. Mishima Y., Ishikawa K., Kawase S. Behcet's syndrome with aneurysm (abstr). In: Proceedings of the Japanese Circulation Society, Tokyo, 1960. Jpn Cir J 1961;25:1211. Uzun O., Akpolat T., Erkan L. Pulmonary vasculitis in Behcet's Disease. A cumulative analysis. Chest 2005;127:2243-53. Erkan F., Cavdar T. Pulmonary vasculitis in Behcet's disease. Am Rev Respir Dis 1992;146:232-9. Erkan F., Gul A., Tasali E. Pulmonary manifestations of Behcet's disease. Thorax 2001;56:572-8. Hiller N., Lieberman S., Chajek-Shaul T. et al. Thoracic manifestations of Behcet's disease at C T. Radio Graphics 2004;24:801-8. Le T., Bletry O., Wcchsler B. et al. Arterial manifestations in Behcet's disease: fifteen cases in a series of 250 patients. Behcet's disease basic and clinical aspects by Desmond O'Duffy and Emre Kokmen-Mayo Clinic, Rochester, Minnesota: Marcel Dekker, Inc., 1991;21:145-53. Park J., Han M., Bettmann M. Arterial manifestations of Behcet's disease. AJR 1984;143:821-5. Raz I., Okon E., Chajek-Shaul T. Pulmonary manifestations in Behcet's syndrome. Chest 1989;95:585-9. Santana A., Antunes T., Barros J. et al. Pulmonary involvement in Behcet's disease: a positive single-center experience with the use of immunosuppressive therapy. J Bras Pneumol 2008;34(6):362-6. Hamuryudan V., Yurdakul S., Moral F. et al. Pulmonary artery aneurysms in Behсet's syndrome: a report of 24 cases. Br J Rheumatol 1994;33:48-51. Chalazonitis A., Lachanis S., Mitseas P. et al. Hughes-Stovin syndrome: a case report and review of the literature. Cases J 2009;2:98. Espinosa G., Cervera R., Reverter J. et al. Vascular involvement in Behcet's disease. Isr Med Assoc J 2002;4(8):614-6. Leiba M., Seligsohn U., Sidi Y. et al. Thrombophilic factors are not leading cause of thrombosis in Behcet's disease. Ann Rheum Dis 2004;63:1445-9. Ko S., Kang S., Lee S. et al. Massive thrombosis after central venous catheterization in a patient with previously undiagnosed Behcet's disease. J Korean Med Sci 2001;16:814-6. Kingston M., Ratcliffe J., Alltree M. et al. Aneurysm after arterial puncture in Behcet's disease. Br Med J 1979;30,1(6180):1766-7. Tunaci M., Ozkorkmaz B., Tunaci A. et al. CT findings of pulmonary artery aneurysms during treatment for Behcet's disease. Am J Roentgenol 1999;172:729-33. Akpolat T., Danaci M., Belet U. et al. MR imaging and MR angiography in vascular Behcet's disease. Magn Reson Imaging 2000;18:1089-96.
-
7Academic Journal
Συγγραφείς: Голоева, Регина, Алекберова, З., Мач, Э., Танковский, В., Калашникова, Л.
Θεματικοί όροι: BEHCET'S DISEASE, БОЛЕЗНЬ БЕХЧЕТА, ВЕНОЗНЫЕ И АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, АНЕВРИЗМЫ АРТЕРИЙ
Περιγραφή αρχείου: text/html
-
8Academic Journal
Πηγή: Акушерство, гинекология и репродукция.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, 3. Good health, ЗАМЕСТИТЕЛЬНАЯ ГОРМОНАЛЬНАЯ ТЕРАПИЯ, ТРОМБОФИЛИЯ, АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ПРОФИЛАКТИКА ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ
Περιγραφή αρχείου: text/html
-
9Academic Journal
Πηγή: Практическая медицина.
Περιγραφή αρχείου: text/html
-
10Academic Journal
Πηγή: Журнал акушерства и женских болезней.
Θεματικοί όροι: АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, ИНСУЛЬТ, БЕРЕМЕННОСТЬ, ТРОМБОФИЛИЯ, 3. Good health
Περιγραφή αρχείου: text/html
-
11Academic Journal
Πηγή: Научно-практическая ревматология.
Θεματικοί όροι: BEHCET'S DISEASE, БОЛЕЗНЬ БЕХЧЕТА, ВЕНОЗНЫЕ И АРТЕРИАЛЬНЫЕ ТРОМБОЗЫ, АНЕВРИЗМЫ АРТЕРИЙ, 3. Good health
Περιγραφή αρχείου: text/html
